EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft

Bastien Le Floc'h, Nathalie Costet, Nicolas Vu, Pénélope Bernabeu-Gentey, Charlotte Pronier, Pauline Houssel-Debry, Karim Boudjéma, Virginie Renac, Michel Samson, Laurence Amiot iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Bastien Le Floc'h und 9 weiteren Autor:innen. Beteiligte Einrichtung: Service de Chirurgie Digestive, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, CHU Rennes, Univ Rennes…. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministère de l’Education Nationale de la Recherche et de la Technologie, University of Rennes 1, Biomedicine Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graft rejection is a critical risk in solid-organ transplantation. To decrease such risk, an understanding of the factors involved in low immunogenicity of liver allografts could potentially make it possible to transfer this tolerogenic property to other transplanted organs. HLA-G, a natural physiological molecule belonging to the Human Leukocyte Antigen class (HLA) Ib family that induces tolerance, is associated with fewer rejections in solid-organ transplantation. In contrast to HLA-G, HLA antigen incompatibilities between donor and recipient can lead to rejection, except in liver transplantation. We compared HLA-G plasma levels and the presence of anti-HLA antibodies before and after LT to understand the low immunogenicity of the liver. We conducted a large prospective study that included 118 patients on HLA-G plasma levels during a 12-month follow-up and compared them to the status of anti-HLA antibodies. HLA-G plasma levels were evaluated by ELISA at seven defined pre- and post-LT time points. HLA-G plasma levels were stable over time pre-LT and were not associated with patient characteristics. The level increased until the third month post-LT, before decreasing to a level comparable to that of the pre-LT period at one year of follow-up. Such evolution was independent of biological markers and immunosuppressive treatment, except with glucocorticoids. An HLA-G plasma level ≤ 50 ng/ml on day 8 after LT was significantly associated with a higher rejection risk. We also observed a higher percentage of rejection in the presence of donor specific anti-HLA antibodies (DSA) and an association between the increase in HLA-G plasma levels at three months and the absence of DSA. The low immunogenicity of liver allografts could be related to early elevated levels of HLA-G, which lead, in turn, to a decrease in anti-HLA antibodies, opening potential new therapeutic strategies using synthetic HLA-G proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHumansHLA-G AntigensProspective StudiesIsoantibodiesLiverHLA AntigensAllograftsGraft RejectionGraft Survival

Substanzen

HLA-G AntigensIsoantibodiesHLA Antigens

Autor:innen und Institutionen

  • Service de Chirurgie Digestive, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, CHU Rennes, Univ Rennes, Rennes, France.
  • Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Univ Rennes, Rennes, France.
  • Pôle de Biologie, Service de Virologie Générale et Rétrovirologie, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, CHU Rennes, Univ Rennes, Rennes, France.
  • Service des Maladies du Foie (SMF), Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, CHU Rennes, Univ Rennes, Rennes, France.
  • EFS Rennes, Laboratoire Histocompatibilité-Immunogénétique / Immunologie Leuco-plaquettaire (HLA/HPA), Rennes, France.
  • Pôle de Biologie, Laboratoire de Cytologie-Cytometrie en flux Inserm, EHESP, IRSET (Institut de Recherche en santé, Environnement et Travail) - UMR_S 1085, CHU Rennes, Univ Rennes, Rennes, France.

ORCID-Profile: Laurence Amiot

Förderung

  • Ministère de l’Education Nationale de la Recherche et de la Technologie
  • University of Rennes 1
  • Biomedicine Agency
  • Région Bretagne
  • Fondation pour la Recherche Médicale

Zitieren

APA

Le Floc'h, B., Costet, N., Vu, N., Bernabeu-Gentey, P., Pronier, C., Houssel-Debry, P., Boudjéma, K., Renac, V., Samson, M., & Amiot, L. (2023). Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft. PLOS ONE. https://doi.org/10.1371/journal.pone.0282736

Vancouver

Le Floc'h B, Costet N, Vu N, Bernabeu-Gentey P, Pronier C, Houssel-Debry P, et al. Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft. PLOS ONE. 2023. doi:10.1371/journal.pone.0282736

BibTeX
@article{LeFloch2023,
  author = {Le Floc'h, Bastien and Costet, Nathalie and Vu, Nicolas and Bernabeu-Gentey, Pénélope and Pronier, Charlotte and Houssel-Debry, Pauline and Boudjéma, Karim and Renac, Virginie and Samson, Michel and Amiot, Laurence},
  title = {Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282736}
}
Kostenlos starten →